When blood sugar starts to rise after a person eats, GLP-1 agonists cause the body to make more insulin. This extra insulin ...

Slimmer waist, weaker buzz? A new study suggests GLP-1 drugs like Ozempic and Wegovy — commonly used for diabetes and weight ...

Novo Nordisk (NVO) plans to run studies on how its GLP-1 class of weight loss/diabetes drug can help people deal with addiction, Martin Holst Lange, the Danish pharma’s head of development, told an ...

Glucagon-like peptide-1 drugs appear to slow the speed at which alcohol enters the bloodstream, which diminishes its effects ...

Eli Lilly's GLP-1 Pill Just Beat Out Novo Nordisk's in a Test. Here's 1 Thing Investors Need to Know. The secondary endpoints included weight loss, and, here again, orforglipron demonstrated ...

For years, the pancreas has been being taught in biology class as an easy system: insulin lowers blood sugar, and glucagon raises it. But that’s much too simple, new research says.

Jabby is a newly launched iOS application for GLP-1 injection tracking, developed following extensive beta testing with over 3,000 users. The app provides comprehensive tools for patients managing ...

Eli Lilly and Company's strong Phase 3 diabetes drug results boost its GLP-1 franchise. Click for my updated look at LLY ...

The multinational food and beverage brand’s chief marketer for North America talks with The Drum at Groceryshop on using AI, ...